Rocket Lab Maintains Analyst Confidence Following Busy Operational Period

Rocket Lab USA has concluded a week of significant activity, marked by two successful launches, new contract announcements, and a key executive presentation. In response, investment firm Cantor Fitzgerald has reaffirmed its positive stance on the company’s stock, maintaining an ‘Overweight’ rating and a price target of $85.

Operational Momentum and Financial Backdrop

The company’s operational tempo has been notably high. In early March, Rocket Lab executed two missions within a six-day window. The first, launched from New Zealand, served a commercial client, while the second, originating from Virginia, conducted a hypersonics test flight for the Defense Innovation Unit. This launch cadence is further supported by recent developments, including the introduction of new solar array technology and a multi-launch agreement with the Earth observation company BlackSky.

Financially, the full-year 2025 outlook depicts a firm in a growth investment phase. Rocket Lab projects revenue of $601.8 million and boasts a substantial backlog of $1.85 billion. These figures are counterbalanced by a projected net loss of $198 million, underscoring the capital-intensive nature of its current expansion.

Diverging Views from Wall Street

The catalyst for Cantor Fitzgerald’s reiterated assessment was a discussion with Rocket Lab’s Chief Financial Officer, Adam Spice, at the Cantor Global Tech Conference. Primary topics included the status of contracts with the Space Development Agency, specifically Tranches 2 and 3, progress on the next-generation Neutron rocket, and the planned launch frequency for the Electron vehicle.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Analyst sentiment on the stock, however, is not uniform. Needham remains bullish, upholding a price target of $95 and citing better-than-expected revenue performance in the fourth quarter. In contrast, Craig-Hallum has adopted a more cautious posture. While the firm raised its price target to $68, it retained a ‘Hold’ rating, expressing concerns over potential margin pressures in the future.

Forward-Looking Catalysts

A critical milestone for Rocket Lab’s long-term growth trajectory is the inaugural launch of its larger Neutron rocket, currently scheduled for the fourth quarter of 2026. The success of this development program is viewed as pivotal for securing future contracts and expanding the order book.

The company has scheduled its Annual Meeting of Shareholders for May 20, 2026. Shareholders wishing to submit proposals must do so by March 22 of that year.